N-Methylation separates methamphetamine's neurotoxic and pharmacologic
effects. In particular, N-methylation eliminates methamphetamine's ne
urotoxic activity while preserving its behavioral pharmacologic activi
ty. The purpose of the present studies was to determine whether N-meth
ylation could also be used to separate fenfluramine's neurotoxic and p
harmacologic effects. Fenfluramine-induced serotonin neurotoxicity was
assessed by measuring serotonin axonal markers 2 weeks after fenflura
mine administration. Pharmacologic effects of fenfluramine were assess
ed by measuring fenfluramine-induced anorexia and fenfluramine discrim
ination. Both fenfluramine and its N-methylated analog, N-methylfenflu
ramine, produced dose-related effects in food intake, drug-discriminat
ion and neurotoxicity studies. Although N-methylation reduced the neur
otoxic potency of fenfluramine, it also reduced its pharmacologic acti
vity. Neurotoxic potency was reduced 4- to 8-fold (depending on brain
region), while pharmacologic potency was reduced 4- to 10-fold (depend
ing on paradigm). Notably, N-methylation did not change the efficacy o
f fenfluramine as a serotonin neurotoxin, anorectic agent or discrimin
ation stimulus. These results indicate that fenfluramine's behavioral
and neurotoxic effects, unlike those of methamphetamine, are not disso
ciated by N-methylation. Further, the present results suggest that the
effectiveness of side-chain nitrogen substitution in separating the b
ehavioral and neurotoxic effects of amphetamine derivatives is strongl
y influenced by ring substitutions. (C) 1997 Elsevier Science B.V.